Clinical Trial Detail

NCT ID NCT03417037
Title An Immuno-Therapy Study of Experimental Medication BMS-986205 Given With Nivolumab With or Without Chemotherapy Compared to Chemotherapy in Participants With Previously Untreated Stage IV or Recurrent Non-Small Cell Lung Cancer
Recruitment Withdrawn
Gender both
Phase Phase III
Variant Requirements yes
Sponsors Bristol-Myers Squibb
Indications

lung non-small cell carcinoma

Therapies

BMS-986205 + Nivolumab

Age Groups: senior adult

Additional content available in CKB BOOST